Opinion|Videos|November 17, 2026

Optimizing HIV Adherence Through Team-Based Care and Diverse Treatment Options

Proactive, team-based coordination keeps patients on oral and injectable therapy alike, and a deep arsenal of mechanisms ensures that adverse effects or resistance never leave a patient without options.

In "Optimizing HIV Adherence Through Team-Based Care and Diverse Treatment Options," the panel explores what effective adherence support looks like in practice.

Dr. Nguyen says adherence starts with education, motivation, and barrier reduction. Multidisciplinary teams must communicate closely, because patients often cannot easily reach a physician or nurse. Pharmacists are the most accessible health care professionals, so they can reinforce why, how, and when to take each medication. For oral therapy, she relies on pill reminders, refill reminders, and automatic refills to keep supply uninterrupted. Long-acting injectables require a different approach built on communication with the clinic. When prior authorizations or refill requests cause delays, proactive coordination keeps patients from approaching the end of their dosing window. Her pharmacy sits inside the physician's office. Each week, the team receives a list of patients due for injections seven days ahead, giving time to resolve problems. Dr. Madison observes that sharing physical space makes care coordination much easier. Dr. Burkhart describes adherence as a collaboration among the patient, care team, provider, pharmacist, and support network. Dr. Madison adds that peer navigators are extremely important.

Dr. Durham then addresses why so many HIV regimens seem to do the same thing. He hears this question often, especially from colleagues outside HIV care. At its simplest, the answer comes down to adverse effects and resistance. A highly effective class may carry an uncommon adverse effect that rules it out for certain patients. An equally effective class with a different mechanism and safety profile is then essential. Resistance works the same way, since a patient resistant to one class needs another that works differently. A deep arsenal lets clinicians build unusual combinations tailored to resistance patterns. Dr. Madison agrees, noting data supporting certain antiretrovirals even in the presence of underlying resistance. Having every option available ensures the right patient gets the right medication at the right time.

Up next, in "Remaining HIV Care Gaps: Access, Stigma, Insurance, and Funding," Dr. Nguyen maps the care gaps that persist across her patient population.

Funding supported by Gilead. Content independently developed by Pharmacy Times.


Related to this article